Keith Hyland
Corporate Officer/Principal bij LABCORP HOLDINGS INC.
Profiel
Keith Hyland is the founder of Medical Neurogenetics LLC.
He is currently working as the Department of Neurochemistry at Laboratory Corp.
of America Holdings.
Previously, he worked as the Laboratory Director at Institute of Metabolic Disease and as the Director-Neurochemistry at Horizon Molecular Medicine.
Dr. Hyland completed his undergraduate and doctorate degrees from Brunel University in 1976 and 1980 respectively.
Actieve functies van Keith Hyland
| Bedrijven | Functie | Begin |
|---|---|---|
| LABCORP HOLDINGS INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Keith Hyland
| Bedrijven | Functie | Einde |
|---|---|---|
| Horizon Molecular Medicine | Corporate Officer/Principal | - |
Medical Neurogenetics LLC
 Medical Neurogenetics LLC Medical/Nursing ServicesHealth Services Medical Neurogenetics LLC specializes in neurogenetic and complex biochemical testing. It offers a complete neurogenetic testing menu and provides NGS tests for various genetic and inherited neurological conditions affecting children and adults, including epilepsy, muscular dystrophy, Parkinson’s, Alzheimer’s, and cellular energetics defects. The company was founded in 2001 and is headquartered in Atlanta, GA. | Oprichter | - |
| Institute of Metabolic Disease | Corporate Officer/Principal | - |
Opleiding van Keith Hyland
| Brunel University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Laboratory Corp. of America Holdings
 Laboratory Corp. of America Holdings Services to the Health IndustryHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
| Institute of Metabolic Disease | |
| Horizon Molecular Medicine | |
Medical Neurogenetics LLC
Medical Neurogenetics LLC Medical/Nursing ServicesHealth Services Medical Neurogenetics LLC specializes in neurogenetic and complex biochemical testing. It offers a complete neurogenetic testing menu and provides NGS tests for various genetic and inherited neurological conditions affecting children and adults, including epilepsy, muscular dystrophy, Parkinson’s, Alzheimer’s, and cellular energetics defects. The company was founded in 2001 and is headquartered in Atlanta, GA. | Health Services |
